CN102824614A - Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation - Google Patents

Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation Download PDF

Info

Publication number
CN102824614A
CN102824614A CN2012103515405A CN201210351540A CN102824614A CN 102824614 A CN102824614 A CN 102824614A CN 2012103515405 A CN2012103515405 A CN 2012103515405A CN 201210351540 A CN201210351540 A CN 201210351540A CN 102824614 A CN102824614 A CN 102824614A
Authority
CN
China
Prior art keywords
tablets
wujin
cell proliferation
rhizoma
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012103515405A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Original Assignee
Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zhengliang Pharmaceutical Technology Co Ltd filed Critical Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority to CN2012103515405A priority Critical patent/CN102824614A/en
Publication of CN102824614A publication Critical patent/CN102824614A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation. The formula of the Wujin tablets comprises the components of pollen typhae, plant soot, leonurus, prepared rehmannia root, charred folium artemisiae argyi, rhizoma sparganii, rhizoma corydalis, rhizoma cyperi, white paeony root, fructus psoraleae, fructus evodiae, rhizoma chuanxiong, curcuma zedoary, elecampane, angelica sinensis and fennel oil. The Wujin tablets have the effects of regulating menstruation and removing stasis and are used for qi depression hysteresis, chest and hypochondrium pain, postpartum blood stasis, lower abdomen pain, dysphoria in chestpalms-soles and emaciation with sallow complexion, the specification is 0.6g per tablet, the tablets are taken orally, four tablets are taken once in the mode of two times per day. The tablets can suppress the PC-3 cell proliferation.

Description

The coal sheet suppresses the application in the PC-3 cell proliferation medicine in preparation
Technical field
The present invention relates to a kind of new purposes of Chinese patent medicine, relate in particular to the coal sheet and suppress the application in the PC-3 cell proliferation medicine in preparation.
Background technology
Carcinoma of prostate is exactly the malignant tumor that betides in the male prostate tissue, is the result of the unusual unordered growth of prostate acinous cell.The sickness rate of carcinoma of prostate has tangible geography and race difference.In developed country and areas such as America and Europes, it is the modal malignant tumor of male, and its mortality rate occupies second of various cancers; In the Asia, its sickness rate is lower than western countries, but is rapid ascendant trend in recent years.
The coal sheet is the exclusive product of Yunnan Prov YongZiTang Pharmaceutical Co., Ltd, does not also have it to suppress the bibliographical information of carcinoma of prostate (PC-3) cell proliferation at present.
Summary of the invention
Goal of the invention: the object of the present invention is to provide the coal sheet to suppress the application in the PC-3 cell proliferation medicine in preparation.
Technical scheme: the coal sheet suppresses the application in the PC-3 cell proliferation medicine in preparation.
The coal tablet recipe is Pollen Typhae, Pulvis Fumi Carbonisatus, Herba Leonuri, Radix Rehmanniae Preparata, Folium Artemisiae Argyi (charcoal), triangular, Rhizoma Corydalis, Rhizoma Cyperi, the Radix Paeoniae Alba, Fructus Psoraleae, Fructus Evodiae, Rhizoma Chuanxiong, Rhizoma Curcumae, the Radix Aucklandiae, Radix Angelicae Sinensis, fennel oil, and regulating menstruation and absorbing clots is used for stagnation of QI knot and stagnates, the twinge of the breast side of body; Postnatal blood stasis, lower abdomen pain, dysphoria with feverish sensation in the chest palms and soles; Emaciation and sallow complexion, specification is every 0.6g, and is oral; One time 4,2 times on the one, find that at present it can suppress the PC-3 cell proliferation.
Beneficial effect: the coal sheet suppresses the PC-3 cell proliferation, and is respond well.
The specific embodiment
The coal sheet suppresses the experimentation data of PC-3 cell proliferation
1 experiment material
1.1 cell strain is used in experiment
Carcinoma of prostate (PC-3), from our company's laboratory cell bank, DMEM+10%FBS is conventional to be cultivated.
1.2 experiment medicine
Research medicine: coal sheet, Yunnan Prov YongZiTang Pharmaceutical Co., Ltd, lot number: 20110423
The medicinal liquid liquid storage: take by weighing 100mg coal sheet and pulverize, be dissolved in the 5ml dehydrated alcohol, 0.2 μ m filter filters, and 500 μ l doff manage packing ,-20 ℃ of storages, and 0.2 μ m filter filters the usefulness of dehydrated alcohol in order to matched group simultaneously.
1.3 experiment reagent
DMEM (the Cat.No.12100-061 Lot.No.758137 of GIBCO company); Hyclone (Hangzhoupro, sky, Zhejiang bio tech ltd Lot.No.100419); NaHCO3 (Shanghai hundred million chemical reagent company limited Cat.No.11810-033Lot.No.1088387 of a specified duration); Trypsin (AMRESCO company lot number: 2010/04); EDTA (AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt (AMRESCO company lot number: 2010242); Streptomycin Sulfate (AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); PBS (laboratory autogamy);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); It is thus clear that-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRAMAX 190); CO2 incubator (FORMA model: 3111); Super-clean bench (the safe and sound manufactured model of Su Jing group: SW-CJ-ZFD); Pure water appearance (U.S. Spring company model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Desk-top electric drying oven with forced convection (the accurate experimental facilities in Shanghai company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) the PC-3 cell carries out routine with DMEM+10%FBS in 37 ℃, 5%CO2 and cultivates (10cm culture dish), when cell grows to logarithmic (log) phase, and collecting cell; Discard culture fluid, PBS fine laundering 3 times adds 3ml 0.25% trypsin-0.04%EDTA; Behind 37 ℃ of digestion 2min,, behind the piping and druming cell it is changed in the centrifuge tube to wherein adding 5ml complete medium neutralization reaction; The centrifugal 5min of 1000rpm, 3 * 104/ml of adjustment concentration of cell suspension.
2) the cell kind is gone in 96 well culture plates, every hole adds cell suspension 180 μ l, and culture plate is put into cell culture incubator, and (37 ℃, 5%CO2) routine is cultivated.
3) according to the cell growing state, generally grow to 50%-70%, add coal sheet solution, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) behind the 24h, continue to cultivate 4h.
5) the buckle method is removed supernatant behind the 4h, claps driedly gently with absorbent paper, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on the shaking table, and crystal is fully dissolved.Measure the light absorption value in each hole at enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide), 6 multiple holes of every settings.
7) result representes with the suppression ratio of medicine pair cell:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repetition 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in Microsoft Excel 2003 softwares, data are represented with mean ± S.D..
4 experimental results
Mtt assay experiment back statistical result showed; Compare with matched group; When dosage reaches 5mg/ml; To PC-3 cell inhibitory effect variant (P < 0.05), dosage this difference when 10mg/>ml has significance (P < 0.01), and utmost point significant difference (P < 0.001) is arranged when dosage reaches 15-20mg/>ml.
Table 1 coal sheet is to PC-3 cell inhibitory effect influence research
Figure BDA00002164739900031
Figure 2012103515405100002DEST_PATH_IMAGE001
Annotate: compare * P < 0.01 with matched group; * P < 0.001
5 experiment conclusion
The coal sheet can suppress the PC-3 cell proliferation, reduces the cell growing number of PC-3 cell, and this effect is time and dose dependent.

Claims (1)

1. the coal sheet suppresses the application in the PC-3 cell proliferation medicine in preparation.
CN2012103515405A 2012-09-20 2012-09-20 Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation Pending CN102824614A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103515405A CN102824614A (en) 2012-09-20 2012-09-20 Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103515405A CN102824614A (en) 2012-09-20 2012-09-20 Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation

Publications (1)

Publication Number Publication Date
CN102824614A true CN102824614A (en) 2012-12-19

Family

ID=47328060

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103515405A Pending CN102824614A (en) 2012-09-20 2012-09-20 Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation

Country Status (1)

Country Link
CN (1) CN102824614A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116139238A (en) * 2023-03-05 2023-05-23 湖南汉森制药股份有限公司 Pharmaceutical composition and preparation method thereof
CN116139239A (en) * 2023-03-05 2023-05-23 湖南汉森制药股份有限公司 Traditional Chinese medicine composition for regulating menstruation and removing blood stasis as well as determination method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036263A (en) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd Corydaline derivative-containing synthesis inhibitor of protein belonging to hsp27 family
CN101219135A (en) * 2007-01-08 2008-07-16 杭州民生药业集团有限公司 Application of zedoary root cyclic diolefine in preparing medicament for treating tumour disease and disease caused by virus
KR101131224B1 (en) * 2009-10-12 2012-03-28 부경대학교 산학협력단 Coumarin compounds from Corydalis heterocarpa and Anticancer composition containing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036263A (en) * 1996-07-25 1998-02-10 Kureha Chem Ind Co Ltd Corydaline derivative-containing synthesis inhibitor of protein belonging to hsp27 family
CN101219135A (en) * 2007-01-08 2008-07-16 杭州民生药业集团有限公司 Application of zedoary root cyclic diolefine in preparing medicament for treating tumour disease and disease caused by virus
KR101131224B1 (en) * 2009-10-12 2012-03-28 부경대학교 산학협력단 Coumarin compounds from Corydalis heterocarpa and Anticancer composition containing the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
张辉等,: "吴茱萸碱诱导前列腺癌PC-3细胞凋亡机制的实验研究", 《中国老年学杂志》, vol. 27, no. 13, 31 July 2007 (2007-07-31), pages 1230 - 1231 *
揭金阶等,: "《临床中成药物学》", 31 October 2004, article "乌金片", pages: 424-425 *
朱晓音等,: "当归提取物对PC3、HeLa、MDA-MB-435 肿瘤细胞增殖的影响", 《山东中医杂志》, vol. 26, no. 11, 30 November 2007 (2007-11-30), pages 776 - 778 *
陈哲等,: "补骨脂酚对PC-3细胞增殖抑制作用研究", 《中国药学会应用药理专业委员会第三届学术会议、中国药理学会制药工业专业委员会第十三届学术会议暨2008生物医药学术论坛论文汇编 》, 31 July 2008 (2008-07-31), pages 114 - 115 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116139238A (en) * 2023-03-05 2023-05-23 湖南汉森制药股份有限公司 Pharmaceutical composition and preparation method thereof
CN116139239A (en) * 2023-03-05 2023-05-23 湖南汉森制药股份有限公司 Traditional Chinese medicine composition for regulating menstruation and removing blood stasis as well as determination method and application thereof
CN116139239B (en) * 2023-03-05 2023-08-22 湖南汉森制药股份有限公司 Traditional Chinese medicine composition for regulating menstruation and removing blood stasis as well as determination method and application thereof
CN116139238B (en) * 2023-03-05 2023-09-08 湖南汉森制药股份有限公司 Pharmaceutical composition and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103494902B (en) Preparation method and application of pseudo-ginseng injury tablets
CN103784738A (en) Extraction method and application of plant composition containing Maca
CN103816368A (en) Extraction method and application of ginseng-containing plant composition
CN103860802B (en) Preparation method and application of Jieguqili tablet
CN102824614A (en) Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation
CN103494885B (en) A kind of preparation method of TONGXIAO BIYAN PIAN and application
CN103690756B (en) A kind of application of Qingfeiyihuo Tablets and preparation method
CN103520446B (en) A kind of preparation method of the Zijin ball that bonesets and application
CN103550738B (en) A kind of preparation method of red mast ease pill and application
CN103720799A (en) Preparation method and application of Huoluo Xiaotong tablets
CN103536733B (en) Preparation method and application of rhizoma cyperi pill with ten precious materials
CN102824406B (en) The red capsule for freeing collateral vessels of dragon suppresses the application in MJ cell proliferation in preparation
CN103690601A (en) Application and preparation method of heart strengthening tablets
CN103494915A (en) Preparation method and application of breast lump dissipating tablet
CN102836261B (en) Application of kidney-tonifying capsules in preparing medicament for inhibiting MDA-MB-157 cell proliferation
CN102824515A (en) Application of Reduqing pills in preparation of medicine for inhibiting A-204 cell proliferation
CN105056105B (en) A kind of preparation method and application of shenmei stomach nourishing granule
CN103638489B (en) Preparation method and application of kidney-tonifying pills
CN103610857B (en) A kind of preparation method and application of returning red pill for traumatic injuries
CN104906260A (en) Preparation method and application of wind-expelling and itching-relieving granule
CN103656016B (en) A kind of preparation method of antiasthmatic pill of perilla fruit and application
CN103656181B (en) A kind of application of tablet for women&#39;s health and tranquilness and preparation method
CN103638487B (en) A kind of preparation method of Babao Ruisheng pill and application
CN103721136A (en) Preparation method and application of pharyngitis tablet
CN103536654A (en) Preparation method and application of blended pill of ligusticum wallichii and tea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121219